Italy · Edizioni Minerva Medica S.p....

workspace_premium Q3 — Endocrinology, Diabetes and Metabolism lock Subscription

Minerva Gastroenterologica e Dietologica

Minerva Gastroenterologica e Dietologica is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 30. It has a best quartile of Q3. It is published in English.

ISSN: 1121-421X

Publisher: Edizioni Minerva Medica S.p.A.

Category: Endocrinology, Diabetes and Metabolism

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD Q3

H-index 30

Acceptance rate pie_chart

36%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

Docs (year)

Docs 3y

150

Total refs

422

Cites 3y

281

Citable 3y

103

Cites/Doc 2y

1.83

Ref/Doc

46.89

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Chronic kidney disease in patients with chronic hepatitis C virus infection

Why candidates for liver transplantation should be considered as frail patients

Endoscopic biliary sphincterotomy on thienopyridine therapy compared to low dose aspirin alone has similar outcomes

Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge

Efficacy and safety of long-term entecavir therapy in a European population

Effects of rifaximin-resistant Bifidobacterium longum W11 in subjects with symptomatic uncomplicated diverticular disease treated with rifaximin

Effectiveness of a nutraceutical supplement containing highly standardized perilla and ginger extracts in patients with functional dyspepsia

Diverticulosis today

Differential diagnosis of solid pancreatic masses

Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study

Cyclosporine for severe steroid-refractory ulcerative colitis: commenting the comment

Complete response for 36 months after BRAF and MEK inhibitor therapy for locally advanced gallbladder melanoma

SHOW MORE ARTICLES

Comparing the dietary habits and social-health behaviors among University students living at or away from home

A place for probiotics and prebiotics in the studies on human microbiota and inflammatory bowel diseases

Challenges and future developments in liver transplantation

Cancer risk, screening and surveillance in primary sclerosing cholangitis

Blue light emitting diodes cripple Helicobacter pylori by targeting its virulence factors

Biological properties and pathogenicity factors of Helicobacter pylori

Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018

Assessing urban minority attitudes for colorectal cancer screening using financial incentives

Anti-TNF combination therapy in inflammatory bowel disease: de novo or selective?

An unexpected case of bifid esophagus

Acute HCV infection after chemotherapy: the need to search for occult HCV before this treatment?

Actual diagnosis of Helicobacter pylori infection

FAQs

SJR is not available (NPD) for Minerva Gastroenterologica e Dietologica in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Minerva Gastroenterologica e Dietologica is 36%.

Minerva Gastroenterologica e Dietologica

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Minerva Gastroenterologica e Dietologica?

What is the APC / publication cost?

What is the acceptance rate?